TRANSDERMAL TESTING
Kymos Group offers GMP and GLP-certified studies for transdermal patches or Transdermal Drug Delivery Systems (TDDS), providing extensive expertise in their analysis and quality control. These dosage forms are designed to deliver active substances through the skin in a systemic, prolonged and constant way, and they present unique challenges in terms of quality, efficacy, and safety.
Our specialized laboratories are equipped with state-of-the-art technologies and techniques, and our team of experienced professionals maintain the highest standards and regulatory requirements basing our studies on the “Guideline on quality of transdermal patches (EMA/CHMP/608924/2014)”, relevant Pharmacopeial monographs, and ICH and CHMP/CVMP guidelines.
We provide support during the whole life cycle of transdermal patches, from formulation, development and stabilities, to routine analysis and reformulations, and we can deliver the following quality control assessments:
CMC & Quality Control Testing of Transdermal Patches
GENERAL QUALITY CONTROL ANALYSES | |
|---|---|
| |
SPECIFIC TESTS FOR TRANSDERMAL PATCHES | |
| |
BIOANALYTICAL STUDIES FOR TRANSDERMAL PATCHES | |
| |
Why choose KYMOS to support your transdermal testing needs
We are FDA and EMA-inspected, GMP-certified, GLP-certified, and committed to GCP compliance, ensuring the highest standards in transdermal patch analyses. As a trusted and reliable partner to pharmaceutical innovators worldwide, we specialize in providing cutting-edge transdermal testing services thanks to our extensive experience in CMC & Quality Control.
We are fully committed to delivering a high quality service with tight timelines and sustainable prices matching the needs of the market and industry.
